The Americas encompass an exceptional diversity of terrestrial, freshwater, and marine ecosystems, ranging from Arctic and boreal environments to temperate forests, deserts, tropical rainforests, savannas, wetlands, high-altitude ecosystems, and highly productive coastal and deep-sea environments. This ecological diversity has generated an equally remarkable chemical diversity of specialized metabolites produced by plants, fungi, bacteria, marine organisms, and plant-associated microorganisms. Natural products chemistry in the Americas has historically contributed important therapeutic agents and chemical prototypes, including quinine from Cinchona species, emetine from Carapichea ipecacuanha, paclitaxel from Taxus brevifolia, podophyllotoxin from Podophyllum species, and marine-derived nucleoside analogs that inspired cytarabine. Despite this scientific legacy, the enormous chemical potential of American biodiversity remains incompletely explored. In recent decades, natural products research in the Americas has evolved from conventional extraction, bioactivity-guided fractionation, and structure elucidation toward integrated workflows combining metabolomics, high-resolution mass spectrometry, nuclear magnetic resonance spectroscopy, molecular networking, genome mining, metagenomics, synthetic biology, chemoinformatic, artificial intelligence, and advanced bioassays. These approaches are particularly relevant to biodiverse regions of Latin America and the Caribbean, where traditional medicinal knowledge provides an important source of hypotheses for chemical investigation. At the same time, natural product research must increasingly incorporate biodiversity conservation, equitable benefit sharing, Indigenous rights, sustainable collection, reproducibility, and regulatory compliance. This review discusses the historical foundations, major ecosystems and chemical resources, representative plant, microbial, and marine natural products, methodological advances, translational challenges, and future opportunities in natural products chemistry across the Americas. We pay particular attention to Latin American biodiversity, where a substantial gap persists between biological richness and the number of natural products successfully translated into standardized medicines. We propose that the next generation of natural products research in the Americas should integrate biodiversity science, traditional knowledge, advanced analytical chemistry, computational biology, synthetic biology, and sustainable biomanufacturing to turn chemical diversity into scientifically validated, socially responsible innovation.